abs163.txt	purpose		to	improve	assessment	of	symptomatic	toxicity	in	cancer	clinical	trialsand	complement	clinician-based	reporting	the	us	national	cancerinstitute	developed	a	measurement	system	called	patient-reported	outcomesversion	common	terminology	criteria	for	adverse	events	(pro-ctcae)	theobjective	this	study	was	examine	content	validity	pro-ctcae	inpatients	undergoing	radiation	therapy	and	establish	anatomic	site-specificitem	sets	implementation	research	methods	materials	patients	receiving	brain	head	neck	breast	thorax	abdomen	or	pelvis	were	recruited	during	final	week	ofradiation	participants	described	side	effects	qualitatively	completedanatomic	site-specific	checklists	indicating	presence	absence	ofsymptomatic	toxicities	drawn	from	library	items	endorsed	by	â‰¥20%of	selected	inclusion	describedqualitatively	analyzed	summarized	notreflected	item	tabulated	results	we	conducted	389	interviews	brain(n	=	46)	(n	69)	134)	30)	=27)	female	36)	male	47)	median	age	62	years	62%	53	solicited	symptoms	reflected	all	reportedradiation-induced	with	exception	phlegm/mucus	production	andmouth/throat	pain	swallowing	eye	dryness/irritation	obstructiveurinary	men	pelvic	skinburns	require	greater	specificity	adequately	reflect	toxicitiesexperienced	conclusions	demonstrates	strong	as	measure	these	provideempirical	support	definition	toassess	site-specificpro-ctcae	herein	are	currently	being	deployed	ourdepartment	via	an	electronic	platform	capture	treatment-related
